Latest Headlines

  1. AGC Biologics Partners With Novelty Nobility For Cell Line Development And Phase I Preparations Of Antibody Drug Candidate 5/5/2025

    AGC Biologics, your friendly CDMO expert, today announced a multiphase partnership with Novelty Nobility Inc., a clinical-stage biotech company based in South Korea.

  2. Merck Breaks Ground On New Biologics And ADC Manufacturing Facility In Delaware 4/29/2025

    Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the start of construction for a $1 billion, 470,000-square-foot state-of-the-art biologics center of excellence in Wilmington, Delaware.

  3. RoosterBio Announces Collaboration With Thermo Fisher Scientific To Advance Cell And Exosome Therapy Manufacturing 4/29/2025

    RoosterBio, Inc., a leading supplier of adult human mesenchymal stem/stromal cells (hMSCs), highly engineered media, and bioprocess development services, today announced a new collaboration with Thermo Fisher Scientific, the world leader in serving science.

  4. Cytiva And Asimov Collaborate On Next Generation Cell Line Design And Process Development 4/29/2025

    Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, is collaborating with Cytiva, a global life sciences leader, to provide customers with an integrated offering for optimized biologics production.

  5. Alconox Announces Extended Shelf Life Of Critical Cleaning Detergents For Life Sciences 4/24/2025

    Alconox Inc. is pleased to announce that we have extended the shelf life of our critical cleaning detergents from 2 years (24 months) to 3.5 years (42 months). This significant improvement in shelf life is based on extensive stability testing, and our goal of continuous improvement. Thus ensuring the continued reliability and performance of our detergents throughout this extended period.

  6. Nikon CeLL Innovation Enters Into A Strategic License Agreement With RoosterBio 4/15/2025

    Nikon CeLL innovation Co., Ltd. (NCLi), a subsidiary of Nikon Corporation has entered into a strategic licensing agreement with RoosterBio, Inc. (RoosterBio), a leading stem cell technology company in the US.

  7. INCOG Biopharma Services Announces Significant 2025 Expansion Efforts, Celebrates 2024 Milestones 4/3/2025

    INCOG BioPharma Services, a leading contract development and manufacturing organization (CDMO) specializing in sterile injectable biopharmaceuticals, has announced strategic expansion projects for 2025. These efforts include the physical expansion of their Fishers-based facilities, scaling up of core filling capabilities, adding significant new finishing capabilities, and strategic hiring focused on attracting top-tier talent.

  8. Parker Launches Innovative Automated Solution For PUPSIT Integration 4/1/2025
  9. AGC Biologics Honored For Excellence In Development And Manufacturing 3/25/2025

    AGC Biologics won two 2025 CDMO Leadership Awards in the “Biologics – Global” and “Cell & Gene – Global” categories, based on independent industry surveys. The recognition highlights the company’s strength in innovation, manufacturing, and quality, and its commitment to supporting biopharma companies worldwide.

  10. Johnson & Johnson Announces $55 Billion Manufacturing Investment In United States 3/21/2025

    Johnson & Johnson, healthcare’s leading, most comprehensive innovation powerhouse, announced manufacturing, research and development, and technology investments of more than $55 billion in the United States over the next four years.